Translation is the process your cells use to read the instructions stored in messenger RNA (mRNA) and build proteins from them. It happens on ribosomes, the molecular machines found in every living cell, and it converts a sequence of genetic “letters” into a chain of amino acids that folds into a functional protein. Translation is one of the most fundamental processes in all of biology, and it operates at remarkable speed: ribosomes in human cells add about six amino acids per second to a growing protein chain, though the rate varies depending on the specific sequence being read.
How the Genetic Code Works
The mRNA molecule carries its instructions in three-letter units called codons. Each codon is a combination of three nucleotide bases (A, U, G, or C), and there are 64 possible combinations. These 64 codons map to just 20 amino acids, which means the code is redundant. Some amino acids, like leucine, serine, and arginine, are each specified by six different codons. Others, like methionine and tryptophan, have only one codon each. Three of the 64 codons don’t code for any amino acid at all. Instead, they act as stop signals that tell the ribosome when the protein is complete.
The code is essentially universal. Bacteria, plants, fungi, and animals all use the same codon-to-amino-acid mapping, which is one of the strongest pieces of evidence that all life on Earth shares a common ancestor.
The Key Molecular Players
Three molecules do most of the heavy lifting during translation. The first is mRNA, which carries the protein-building instructions copied from DNA. It threads through the ribosome like a tape through a reader, and the ribosome holds it in place entirely through interactions with its sugar-phosphate backbone.
The second is transfer RNA (tRNA), a small molecule shaped roughly like a cloverleaf. Each tRNA carries a specific amino acid on one end and has a three-letter anticodon on the other end that matches a complementary codon on the mRNA. When a tRNA’s anticodon pairs with the correct mRNA codon, it delivers its amino acid to the growing protein chain.
The third is the ribosome itself, which is made of two subunits. In human cells, these are called the 40S (small) and 60S (large) subunits, which combine to form the full 80S ribosome. Bacterial ribosomes are slightly smaller, with 30S and 50S subunits forming a 70S ribosome. The small subunit is responsible for reading the mRNA and matching codons to tRNAs, while the large subunit catalyzes the chemical bond that links amino acids together. The ribosome has three internal slots for tRNA: the A site (where new amino acid-carrying tRNAs arrive), the P site (where the growing chain is held), and the E site (where empty tRNAs exit).
Initiation: Starting the Process
Translation begins when the small ribosomal subunit locates the start codon on the mRNA. This start codon is almost always AUG, which codes for methionine, so nearly every newly made protein begins with that amino acid. In human cells, the small subunit first binds to the front end of the mRNA and then scans along it until it finds the AUG. A surrounding sequence called the Kozak sequence helps the ribosome recognize the correct start site.
Bacteria use a different recognition strategy. Instead of scanning, they rely on a short sequence in the mRNA called the Shine-Dalgarno sequence, an AG-rich stretch that base-pairs directly with a complementary region on the ribosome’s own RNA. This interaction positions the ribosome right at the start codon. Once the start codon is found, a special initiator tRNA carrying methionine slots into the P site, and the large ribosomal subunit joins. The full ribosome is now assembled and ready to build the protein. This assembly process requires at least ten helper proteins (called initiation factors) in human cells.
Elongation: Building the Protein
With the ribosome locked onto the mRNA, the elongation cycle begins. Each cycle adds one amino acid and involves three steps. First, a tRNA carrying the correct amino acid enters the A site. The ribosome checks whether the tRNA’s anticodon matches the mRNA codon currently exposed in the A site. If it’s a match, the tRNA is accepted. Second, the ribosome forms a peptide bond, linking the new amino acid to the growing chain. Third, the ribosome shifts forward by exactly three nucleotides along the mRNA, moving the now-empty tRNA to the E site and the chain-carrying tRNA into the P site. This opens up the A site for the next incoming tRNA.
This cycle repeats hundreds or thousands of times, depending on the length of the protein. The speed isn’t uniform. Some codons are read in as little as 0.08 seconds, while others take up to 0.5 seconds, likely because some tRNAs are more abundant than others in the cell.
Termination: Releasing the Finished Protein
Translation stops when the ribosome encounters one of three stop codons: UAA, UAG, or UGA. No tRNA molecules recognize these codons. Instead, proteins called release factors enter the A site and trigger the ribosome to release the finished amino acid chain. The ribosome then splits back into its two subunits, the mRNA is freed, and both can be reused for another round of translation.
What Happens After Translation
A freshly made amino acid chain isn’t immediately a working protein. It first needs to fold into a precise three-dimensional shape, and in many cases it also undergoes chemical modifications. These post-translational modifications alter the protein’s behavior, stability, or location within the cell. The three most common types are phosphorylation (adding a phosphate group), acetylation (adding an acetyl group), and ubiquitination (tagging a protein for destruction). Together, these three account for over 90% of all known modification sites.
Glycosylation, the attachment of sugar molecules, is one of the most complex modifications and takes place in several locations within the cell, including the endoplasmic reticulum and the Golgi apparatus. These sugar tags are critical for proteins that will be secreted from the cell or embedded in its membrane.
How Cells Control Translation
Protein synthesis is one of the most energy-intensive activities a cell performs, so cells tightly regulate when and how much translation occurs. Under stress, such as nutrient starvation, viral infection, or the accumulation of misfolded proteins, cells can rapidly shut down most translation.
The primary shutdown mechanism targets the initiation step. Cells have four different stress-sensing enzymes that each respond to a specific threat. One activates during amino acid starvation when uncharged tRNAs accumulate. Another responds to viral infection by detecting double-stranded RNA. A third senses problems in the cell’s protein-folding machinery. A fourth responds to oxidative stress and heat shock. Despite their different triggers, all four enzymes converge on the same target: they chemically modify a key initiation factor, which prevents the ribosome from loading the first tRNA and effectively halts new protein production.
A second regulatory pathway involves a cellular nutrient sensor called mTORC1. When nutrients are plentiful, mTORC1 keeps translation running by disabling proteins that would otherwise block initiation. When nutrients run low, mTORC1 shuts off, those blocking proteins become active, and global translation drops.
Why Translation Matters in Medicine
The differences between bacterial and human ribosomes are a cornerstone of antibiotic therapy. Because bacterial ribosomes (70S) are structurally distinct from human ribosomes (80S), drugs can target bacterial translation without harming human cells. Tetracyclines and aminoglycosides like gentamicin bind to the small bacterial subunit and interfere with codon reading. Chloramphenicol, linezolid, and clindamycin bind to the large bacterial subunit and block the formation of peptide bonds. Macrolide antibiotics like erythromycin clog the tunnel through which the growing protein chain exits the ribosome. Each of these drug classes exploits a different step in the translation process, giving doctors multiple tools to fight bacterial infections.
Errors in translation regulation also play a role in diseases like cancer, where cells often hijack translational control to ramp up production of growth-promoting proteins. Understanding the mechanics of translation has opened the door to therapies that target these regulatory pathways directly.